After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...
This important study examines the potential role of ARHGAP36 transcriptional regulation by FOXC1 in controlling sonic hedgehog signaling in human neuroblastoma. While there are many solid findings ...
Researchers have shown for the first time that flipping an epigenetic “switch” in specific memory-holding neurons can directly alter memory strength.
Signals from the plant cell wall help to orchestrate growth, reproduction and immune function. Can harnessing this molecular ...
Cancer therapies save lives but often cause neurologic damage, so we must recognize the full scope of neurotoxicity, from ...
Virginia Tech scientists found that age-related memory loss stems from molecular changes in the brain. Memory decline might not be just a natural part of aging. Researchers at Virginia Tech have ...
The mice model technologies market offers significant opportunities driven by advancements in genetic engineering, particularly CRISPR/Cas9, fueling drug discovery in oncology, neurobiology, and ...
In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...
The FDA has officially placed two of Intellia’s Phase III studies under clinical hold after the biotech reported earlier this ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback